{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:11:17Z","timestamp":1791213077147,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hypertensive disorders are among the most common medical problems in pregnancy. Compliance with clinical practice guidelines has potential to translate to significant maternal and perinatal health benefits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To evaluate compliance with Society of Obstetric Medicine of Australia and New Zealand (<jats:styled-content style=\"fixed-case\">SOMANZ<\/jats:styled-content>) clinical guidelines for management of hypertension during pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Inclusion criteria: women with hypertension in pregnancy who gave birth at a tertiary obstetric centre in 2010. Compliance with <jats:styled-content style=\"fixed-case\">SOMANZ<\/jats:styled-content> guidelines was assessed, as well as uptake of findings from the \u2018Induction of labour versus expectant monitoring for mild gestational hypertension\/pre\u2010eclampsia after 36 weeks\u2019 gestation\u2019 (<jats:styled-content style=\"fixed-case\">HYPITAT<\/jats:styled-content>) trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 5624 women, 516 (9.2%) were identified with hypertension (49 chronic hypertension (<jats:styled-content style=\"fixed-case\">CH)<\/jats:styled-content>; 457 gestational hypertension <jats:bold>(<\/jats:bold><jats:styled-content style=\"fixed-case\">GH)<\/jats:styled-content> or pre\u2010eclampsia (<jats:styled-content style=\"fixed-case\">PE)<\/jats:styled-content>). Thresholds to diagnose hypertension and initiate anti\u2010hypertensive treatment were consistent with <jats:styled-content style=\"fixed-case\">SOMANZ<\/jats:styled-content> recommendations. Among women with <jats:styled-content style=\"fixed-case\">CH<\/jats:styled-content>, only 12.2% were prescribed aspirin prior to 16 weeks as <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> prophylaxis. Of women with <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>, 37 (18.6%) had known risk factors for development of <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> at the initial visit yet only nine (24.3%) received aspirin. Of the 244 women who met <jats:styled-content style=\"fixed-case\">HYPITAT<\/jats:styled-content> inclusion criteria at 36 weeks, 174 (77.7%) were managed expectantly; nine (5.2%) developed severe adverse outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Current management guidelines for hypertension treatment were generally followed, although aspirin prophylaxis was frequently overlooked, resulting in up to 19 excess <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> cases. Uptake of recommendations from the <jats:styled-content style=\"fixed-case\">HYPITAT<\/jats:styled-content> trial was low; however, severe complications were fewer than expected. Overall, this suggests that clinicians appropriately weigh up the likely maternal risk compared to infant benefits of deferred delivery in each case, a key recommendation of <jats:styled-content style=\"fixed-case\">HYPITAT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajo.12499","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T09:54:36Z","timestamp":1468230876000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of pregnancies complicated by hypertensive disorders of pregnancy: Could we do better?"],"prefix":"10.1111","volume":"57","author":[{"given":"Amyna","family":"Helou","sequence":"first","affiliation":[{"name":"Centre for Medicine Use and Safety Faculty of Pharmacy and Pharmaceutical Sciences Monash University Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Perinatal Medicine Mercy Hospital for Women Melbourne Victoria Australia"},{"name":"Department of Obstetrics and Gynaecology University of Melbourne Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Stewart","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety Faculty of Pharmacy and Pharmaceutical Sciences Monash University Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"George","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety Faculty of Pharmacy and Pharmaceutical Sciences Monash University Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06730.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000120122.39231.88"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2009.01003.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12253"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60736-4"},{"key":"e_1_2_6_7_1","unstructured":"World Health Organisation.ICD.Chapter XV Pregnancy childbirth and the puerperium (O00\u2010O99) Oedema proteinuria and hypertensive disorders in pregnancy childbirth and the puerperium (O10\u2010O16)."},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2007.00698.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2012-0179"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e318280da0f"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2012.02.002"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.01.007"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-2257"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61998-X"},{"key":"e_1_2_6_15_1","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2","author":"Abalos E","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.09.032"},{"issue":"1","key":"e_1_2_6_17_1","first-page":"1","article-title":"Saving Mothers\u2019 Lives: reviewing maternal deaths to make motherhood safer: 2006\u20102008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom","volume":"118","author":"Cantwell R","year":"2011","journal-title":"BJOG"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404595"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200208000-00029"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e9322a"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2844"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000336662"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajo.12499","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajo.12499","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.12499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:39:27Z","timestamp":1695541167000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.12499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1111\/ajo.12499"],"URL":"https:\/\/doi.org\/10.1111\/ajo.12499","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]},"assertion":[{"value":"2015-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}